ÂÜÀòÂÒÂ×

Jennifer (Goldenberg) Klarer, M.Sc.Eng. currently works at The Dedham Group as a Partner and Head of Cell & Gene Therapy, a role they started in December 2022. Before this, they held positions of Associate Partner, Principal, Engagement Manager, Senior Consultant, Consultant, Associate Consultant, Senior Analyst, and Analyst within the company, with their earliest starting in January 2016. Jennifer also has experience as a Cell & Tissue Engineering Research Associate at Columbia University in the City of New York, where they conducted research on autologous cell therapy solutions for Critical Limb Ischemia from October 2014 to December 2015. Prior to that, they were an Apatite Structural Research Associate at Franklin & Marshall College, focusing on the synthesis and structure analysis of carbonated apatite minerals from June 2010 to May 2014.

Jennifer (Goldenberg) Klarer, M.Sc.Eng. has a Bachelor of Arts (B.A.) degree in Chemistry with concentrations in Math and Physics from Franklin & Marshall College. Subsequently, they pursued a Master of Science in Engineering (M.Sc.Eng.) degree in Bioengineering and Biomedical Engineering from Columbia Engineering. No specific start or end years were provided for either school.